Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Daniel O'Day
Age : 56
Public asset : 14,796,073 USD
Country of residence : Unknown
Linked companies : Gilead Sciences, Inc. - Galapagos NV

Biography of Daniel O'Day 
Mr. Daniel P. O'Day is a Chairman & Chief Executive Officer at Gilead Sciences, Inc. He is on the Board of Directors at Galapagos NV, Flatiron Health, Inc., Pharmaceutical Manufacturers Association of America, Pharmaceutical Research & Manufacturers of America and Shanghai Roche Pharmaceuticals Ltd. Mr. O'Day was previously employed as a President & Chief Executive Officer by Roche Molecular Systems, Inc., a General Manager by Roche A/S Medicinalvarer OG Kemikalier, a Chief Operating Officer by Roche Diagnostics A/S, a Head-Business Unit, Arthritis & Respiratory by Roche Pharma Schweiz AG, a Chief Executive Officer by Roche Pharmaceuticals, Inc., a Head-Corporate Planning by Roche Diagnostics KK, and a CEO-Roche Pharmaceuticals by Roche Holding AG. He also served on the board at Foundation Medicine, Inc., Chugai Pharmaceutical Co., Ltd., Genentech, Inc. and Roche Diagnostics GmbH. He received his undergraduate degree from Georgetown University and an MBA from The Trustees of Columbia University in The City of New York.


Current positions of Daniel O'Day 
Holdings of Daniel O'Day 
Daniel O'Day : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/09ELON MUSK : Musk tweet on Japan doomed by low birthrate provokes anger - but not just at him
RE
More news


© 2022 People and Ownership :   
Daniel O'Day : Connections 


Latest news about Daniel O'Day 
04/28TRANSCRIPT : Gilead Sciences, Inc., Q1 2022 Earnings Call, Apr 28, 2022
CI
04/14TRANSCRIPT : Gilead Sciences, Inc. - Special Call
CI
02/01TRANSCRIPT : Gilead Sciences, Inc., Q4 2021 Earnings Call, Feb 01, 2022
CI
01/10TRANSCRIPT : Gilead Sciences, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 11:15 AM
CI
2021Gilead trims 2021 sales forecast for non-COVID products
RE
2021Gilead trims 2021 sales forecast for non-COVID products
RE
More news